US PATENT SUBCLASS 424 / 144.1
.~.~.~ Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., NK cell, etc.)

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

130.1  DF  IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL {18}
141.1  DF  .~ Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) {8}
143.1  DF  .~.~ Binds receptor {1}
144.1.~.~.~ Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., NK cell, etc.)

DEFINITION

Classification: 424/144.1

Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., NK cell, etc.):

(under subclass 143.1) Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a receptor integral to or derived from a lymphocytic or a lymphocytic-like cell.

(1) Note. Lymphocytic cells are considered either B- or T-lineage cells. Null cells, or K cells, and natural killer cells are considered to be "lymphocytic-like" cells, since they have the morphology of lymphocytes, but not the antigenic markers of either B- or T-lineage cells.